PAI
SVNT

Palo Alto Investors’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Palo Alto Investors’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,752,981
Closed -$5.46M – 36
2013
Q3 		$5.46M Sell
8,752,981
-991,852
-10% -$635K 0.57% 24
2013
Q2 		$5.46M Buy
+9,744,833
New +$6.79M 0.64% 22

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Palo Alto Investors's SVNT Position: Q4 2013 in Review

Palo Alto Investors sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 8,752,981 shares — an estimated $5.46M sold.

Palo Alto Investors first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $5.46M in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Palo Alto Investors reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Palo Alto Investors sold 8,752,981 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $5.46M.
  • Palo Alto Investors first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Palo Alto Investors's SAVIENT PHARMACEUTICALS INC position peaked at $5.46M in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Palo Alto Investors's 13F filing for Q4 2013, filed 13 Feb 2014.